Global Host Cell Protein Testing

Host Cell Protein Testing Comprehensive Study by Type (PCR-Based Assays, ELISA-Based Assays, Mass Spectrometry-Based Assays, Others), Host Cell Type (Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces), Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals)), End User (Hospitals & Diagnostic Centers, Research Institutes, Pharmaceutical Companies) Players and Region - Global Market Outlook to 2030

Host Cell Protein Testing Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Host Cell Protein Testing Market Overview:
Host Cell Protein (HCP) testing represents an essential feature in the process of making pharmaceuticals from living things especially when it comes to making monoclonal antibodies and other drugs with cells that grow in labs. Such host cells always produce some proteins called HCPs which need to be examined carefully prior any other steps taken towards manufacturing biopharmaceuticals. Growing biopharmaceutical development emphasize the importance of robust host cell protein (HCP) testing to mitigate potential immune reactions induced by proteins left behind by the production host. New technologies such as mass spectrometry have greatly improved the accuracy and range of HCP detection methods, providing a comprehensive assessment of biological purity. Further, Regulatory agencies around the world have imposed strict guidelines that require thorough HCP testing at various stages of biomedical development and manufacturing to ensure product quality and safety.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Development of Advanced Host Cell Protein Testing Methods Such as Mass Spectrometry and Next-Generation Sequencing

Market Growth Drivers:
Growing Demand of Biopharmaceuticals and Novel Therapies for Various Diseases and Rapidly Increasing Chronic and Autoimmune Diseases Across the Globe

Challenges:
High Cost Associated With Advanced HCP Testing Methods That May Create Challenges for Small Pharmaceutical Companies

Restraints:
Stringent Regulatory Guidelines and Latest Standards for HCP Testing

Opportunities:
Outsourcing of Host Cell Protein Testing By Pharmaceutical Companies May Create Opportunities and Robust Growth of Biopharmaceutical Industry in Asia Pacific Region

Competitive Landscape:
The key players are targeting the innovations of the Solutions with better quality, better technical characteristics. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking upon mergers and acquisitions in order to maintain their presence in the market.
Some of the key players profiled in the report are Bio-Rad Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Alphalyse (United States), Cytiva (United States), Charles River Laboratories (United States), Revvity Holdings, Inc. (United States), Krishgen Biosystems (United States), Laboratory Corporation of America (United States), Cygnus Technologies (United States), Agilent Technologies, Inc. (United States), Abcam Limited (United Kingdom), BioGenes GmbH (Germany) and Enzo Biochem Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Host Cell Protein Testing market by 2030. Considering Market by Host Cell Type, the sub-segment i.e. Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces) will boost the Host Cell Protein Testing market. Considering Market by End User, the sub-segment i.e. Hospitals & Diagnostic Centers will boost the Host Cell Protein Testing market.

What Can be Explored with the Host Cell Protein Testing Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Host Cell Protein Testing Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Host Cell Protein Testing
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Host Cell Protein Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Host Cell Protein Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Host Cell Protein Testing Kit Manufacturers, Biopharma Outsourcing Service Providers, Venture Capitalists and Private Equity Firms, Government Bodies, Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • PCR-Based Assays
  • ELISA-Based Assays
  • Mass Spectrometry-Based Assays
  • Others
By Host Cell Type
  • Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces)
  • Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals)

By End User
  • Hospitals & Diagnostic Centers
  • Research Institutes
  • Pharmaceutical Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand of Biopharmaceuticals and Novel Therapies for Various Diseases
      • 3.2.2. Rapidly Increasing Chronic and Autoimmune Diseases Across the Globe
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated With Advanced HCP Testing Methods That May Create Challenges for Small Pharmaceutical Companies
    • 3.4. Market Trends
      • 3.4.1. Development of Advanced Host Cell Protein Testing Methods Such as Mass Spectrometry and Next-Generation Sequencing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Host Cell Protein Testing, by Type, Host Cell Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Host Cell Protein Testing (Value)
      • 5.2.1. Global Host Cell Protein Testing by: Type (Value)
        • 5.2.1.1. PCR-Based Assays
        • 5.2.1.2. ELISA-Based Assays
        • 5.2.1.3. Mass Spectrometry-Based Assays
        • 5.2.1.4. Others
      • 5.2.2. Global Host Cell Protein Testing by: Host Cell Type (Value)
        • 5.2.2.1. Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces)
        • 5.2.2.2. Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals)
      • 5.2.3. Global Host Cell Protein Testing by: End User (Value)
        • 5.2.3.1. Hospitals & Diagnostic Centers
        • 5.2.3.2. Research Institutes
        • 5.2.3.3. Pharmaceutical Companies
      • 5.2.4. Global Host Cell Protein Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Host Cell Protein Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alphalyse (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cytiva (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Charles River Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Revvity Holdings, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Krishgen Biosystems (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Laboratory Corporation of America (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cygnus Technologies (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Abcam Limited (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. BioGenes GmbH (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Enzo Biochem Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Host Cell Protein Testing Sale, by Type, Host Cell Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Host Cell Protein Testing (Value)
      • 7.2.1. Global Host Cell Protein Testing by: Type (Value)
        • 7.2.1.1. PCR-Based Assays
        • 7.2.1.2. ELISA-Based Assays
        • 7.2.1.3. Mass Spectrometry-Based Assays
        • 7.2.1.4. Others
      • 7.2.2. Global Host Cell Protein Testing by: Host Cell Type (Value)
        • 7.2.2.1. Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces)
        • 7.2.2.2. Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals)
      • 7.2.3. Global Host Cell Protein Testing by: End User (Value)
        • 7.2.3.1. Hospitals & Diagnostic Centers
        • 7.2.3.2. Research Institutes
        • 7.2.3.3. Pharmaceutical Companies
      • 7.2.4. Global Host Cell Protein Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Host Cell Protein Testing: by Type(USD Million)
  • Table 2. Host Cell Protein Testing PCR-Based Assays , by Region USD Million (2018-2023)
  • Table 3. Host Cell Protein Testing ELISA-Based Assays , by Region USD Million (2018-2023)
  • Table 4. Host Cell Protein Testing Mass Spectrometry-Based Assays , by Region USD Million (2018-2023)
  • Table 5. Host Cell Protein Testing Others , by Region USD Million (2018-2023)
  • Table 6. Host Cell Protein Testing: by Host Cell Type(USD Million)
  • Table 7. Host Cell Protein Testing Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces) , by Region USD Million (2018-2023)
  • Table 8. Host Cell Protein Testing Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals) , by Region USD Million (2018-2023)
  • Table 9. Host Cell Protein Testing: by End User(USD Million)
  • Table 10. Host Cell Protein Testing Hospitals & Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 11. Host Cell Protein Testing Research Institutes , by Region USD Million (2018-2023)
  • Table 12. Host Cell Protein Testing Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 13. South America Host Cell Protein Testing, by Country USD Million (2018-2023)
  • Table 14. South America Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 15. South America Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 16. South America Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 17. Brazil Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 18. Brazil Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 19. Brazil Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 20. Argentina Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 21. Argentina Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 22. Argentina Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 23. Rest of South America Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 25. Rest of South America Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 26. Asia Pacific Host Cell Protein Testing, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 29. Asia Pacific Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 30. China Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 31. China Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 32. China Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 33. Japan Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 34. Japan Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 35. Japan Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 36. India Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 37. India Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 38. India Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 39. South Korea Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 40. South Korea Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 41. South Korea Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 42. Taiwan Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 43. Taiwan Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 44. Taiwan Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 45. Australia Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 46. Australia Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 47. Australia Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 51. Europe Host Cell Protein Testing, by Country USD Million (2018-2023)
  • Table 52. Europe Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 53. Europe Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 54. Europe Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 55. Germany Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 56. Germany Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 57. Germany Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 58. France Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 59. France Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 60. France Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 61. Italy Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 62. Italy Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 63. Italy Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 64. United Kingdom Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 66. United Kingdom Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 67. Netherlands Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 68. Netherlands Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 69. Netherlands Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 70. Rest of Europe Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 72. Rest of Europe Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 73. MEA Host Cell Protein Testing, by Country USD Million (2018-2023)
  • Table 74. MEA Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 75. MEA Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 76. MEA Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 77. Middle East Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 78. Middle East Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 79. Middle East Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 80. Africa Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 81. Africa Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 82. Africa Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 83. North America Host Cell Protein Testing, by Country USD Million (2018-2023)
  • Table 84. North America Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 85. North America Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 86. North America Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 87. United States Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 88. United States Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 89. United States Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 90. Canada Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 91. Canada Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 92. Canada Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 93. Mexico Host Cell Protein Testing, by Type USD Million (2018-2023)
  • Table 94. Mexico Host Cell Protein Testing, by Host Cell Type USD Million (2018-2023)
  • Table 95. Mexico Host Cell Protein Testing, by End User USD Million (2018-2023)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Host Cell Protein Testing: by Type(USD Million)
  • Table 110. Host Cell Protein Testing PCR-Based Assays , by Region USD Million (2025-2030)
  • Table 111. Host Cell Protein Testing ELISA-Based Assays , by Region USD Million (2025-2030)
  • Table 112. Host Cell Protein Testing Mass Spectrometry-Based Assays , by Region USD Million (2025-2030)
  • Table 113. Host Cell Protein Testing Others , by Region USD Million (2025-2030)
  • Table 114. Host Cell Protein Testing: by Host Cell Type(USD Million)
  • Table 115. Host Cell Protein Testing Prokaryotic Hosts (E.coli, Bacillus, Pseudomonas, Streptomyces) , by Region USD Million (2025-2030)
  • Table 116. Host Cell Protein Testing Eukaryotic Hosts (Yeast, Fungi, Algae, Plants, Animals) , by Region USD Million (2025-2030)
  • Table 117. Host Cell Protein Testing: by End User(USD Million)
  • Table 118. Host Cell Protein Testing Hospitals & Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 119. Host Cell Protein Testing Research Institutes , by Region USD Million (2025-2030)
  • Table 120. Host Cell Protein Testing Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 121. South America Host Cell Protein Testing, by Country USD Million (2025-2030)
  • Table 122. South America Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 123. South America Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 124. South America Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 125. Brazil Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 126. Brazil Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 127. Brazil Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 128. Argentina Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 129. Argentina Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 130. Argentina Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 131. Rest of South America Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 132. Rest of South America Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 133. Rest of South America Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 134. Asia Pacific Host Cell Protein Testing, by Country USD Million (2025-2030)
  • Table 135. Asia Pacific Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 136. Asia Pacific Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 137. Asia Pacific Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 138. China Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 139. China Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 140. China Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 141. Japan Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 142. Japan Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 143. Japan Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 144. India Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 145. India Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 146. India Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 147. South Korea Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 148. South Korea Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 149. South Korea Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 150. Taiwan Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 151. Taiwan Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 152. Taiwan Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 153. Australia Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 154. Australia Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 155. Australia Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 159. Europe Host Cell Protein Testing, by Country USD Million (2025-2030)
  • Table 160. Europe Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 161. Europe Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 162. Europe Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 163. Germany Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 164. Germany Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 165. Germany Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 166. France Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 167. France Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 168. France Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 169. Italy Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 170. Italy Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 171. Italy Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 172. United Kingdom Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 173. United Kingdom Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 174. United Kingdom Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 175. Netherlands Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 176. Netherlands Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 177. Netherlands Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 178. Rest of Europe Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 179. Rest of Europe Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 180. Rest of Europe Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 181. MEA Host Cell Protein Testing, by Country USD Million (2025-2030)
  • Table 182. MEA Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 183. MEA Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 184. MEA Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 185. Middle East Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 186. Middle East Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 187. Middle East Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 188. Africa Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 189. Africa Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 190. Africa Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 191. North America Host Cell Protein Testing, by Country USD Million (2025-2030)
  • Table 192. North America Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 193. North America Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 194. North America Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 195. United States Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 196. United States Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 197. United States Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 198. Canada Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 199. Canada Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 200. Canada Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 201. Mexico Host Cell Protein Testing, by Type USD Million (2025-2030)
  • Table 202. Mexico Host Cell Protein Testing, by Host Cell Type USD Million (2025-2030)
  • Table 203. Mexico Host Cell Protein Testing, by End User USD Million (2025-2030)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Host Cell Protein Testing: by Type USD Million (2018-2023)
  • Figure 5. Global Host Cell Protein Testing: by Host Cell Type USD Million (2018-2023)
  • Figure 6. Global Host Cell Protein Testing: by End User USD Million (2018-2023)
  • Figure 7. South America Host Cell Protein Testing Share (%), by Country
  • Figure 8. Asia Pacific Host Cell Protein Testing Share (%), by Country
  • Figure 9. Europe Host Cell Protein Testing Share (%), by Country
  • Figure 10. MEA Host Cell Protein Testing Share (%), by Country
  • Figure 11. North America Host Cell Protein Testing Share (%), by Country
  • Figure 12. Global Host Cell Protein Testing share by Players 2023 (%)
  • Figure 13. Global Host Cell Protein Testing share by Players (Top 3) 2023(%)
  • Figure 14. Global Host Cell Protein Testing share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 18. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Alphalyse (United States) Revenue, Net Income and Gross profit
  • Figure 21. Alphalyse (United States) Revenue: by Geography 2023
  • Figure 22. Cytiva (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cytiva (United States) Revenue: by Geography 2023
  • Figure 24. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Charles River Laboratories (United States) Revenue: by Geography 2023
  • Figure 26. Revvity Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Revvity Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Krishgen Biosystems (United States) Revenue, Net Income and Gross profit
  • Figure 29. Krishgen Biosystems (United States) Revenue: by Geography 2023
  • Figure 30. Laboratory Corporation of America (United States) Revenue, Net Income and Gross profit
  • Figure 31. Laboratory Corporation of America (United States) Revenue: by Geography 2023
  • Figure 32. Cygnus Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 33. Cygnus Technologies (United States) Revenue: by Geography 2023
  • Figure 34. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Agilent Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Abcam Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Abcam Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 38. BioGenes GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 39. BioGenes GmbH (Germany) Revenue: by Geography 2023
  • Figure 40. Enzo Biochem Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Enzo Biochem Inc. (United States) Revenue: by Geography 2023
  • Figure 42. Global Host Cell Protein Testing: by Type USD Million (2025-2030)
  • Figure 43. Global Host Cell Protein Testing: by Host Cell Type USD Million (2025-2030)
  • Figure 44. Global Host Cell Protein Testing: by End User USD Million (2025-2030)
  • Figure 45. South America Host Cell Protein Testing Share (%), by Country
  • Figure 46. Asia Pacific Host Cell Protein Testing Share (%), by Country
  • Figure 47. Europe Host Cell Protein Testing Share (%), by Country
  • Figure 48. MEA Host Cell Protein Testing Share (%), by Country
  • Figure 49. North America Host Cell Protein Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories, Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Alphalyse (United States)
  • Cytiva (United States)
  • Charles River Laboratories (United States)
  • Revvity Holdings, Inc. (United States)
  • Krishgen Biosystems (United States)
  • Laboratory Corporation of America (United States)
  • Cygnus Technologies (United States)
  • Agilent Technologies, Inc. (United States)
  • Abcam Limited (United Kingdom)
  • BioGenes GmbH (Germany)
  • Enzo Biochem Inc. (United States)
Select User Access Type

Key Highlights of Report


Jun 2024 234 Pages 60 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Host Cell Protein Testing Quantitative research analysis
Global Host Cell Protein Testing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Host Cell Protein Testing market are Bio-Rad Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Alphalyse (United States), Cytiva (United States), Charles River Laboratories (United States), Revvity Holdings, Inc. (United States), Krishgen Biosystems (United States), Laboratory Corporation of America (United States), Cygnus Technologies (United States), Agilent Technologies, Inc. (United States), Abcam Limited (United Kingdom), BioGenes GmbH (Germany) and Enzo Biochem Inc. (United States), to name a few.
"Development of Advanced Host Cell Protein Testing Methods Such as Mass Spectrometry and Next-Generation Sequencing" is seen as one of major influencing trends for Host Cell Protein Testing Market during projected period 2023-2030.
PCR-Based Assays segment in Global market to hold robust market share owing to "Growing Demand of Biopharmaceuticals and Novel Therapies for Various Diseases ".

Know More About Global Host Cell Protein Testing Report?

Have a Query? Click Here

Other Related Reports

Benchtop Centrifuge Comprehensive Study by Type (Refrigerated, Non-Refrigerated), Application (Pharmaceutical Industry, Health Care Industry, Educational and Research Institutes, Others), Sales Chann...
$ 3650
Rapid Antibody and Antigen Testing Kit Comprehensive Study by Components (50 Strips /Tests Per Box, 1x Test Cassette, 1x Desiccant Pouch, 25x Disposable Pipettes, Sample Diluent), Disease (Autoimmune...
$ 3750
Food Testing, Inspection, and Certification Comprehensive Study by Services (Testing, Inspection, Certification), End Users (Consumer Goods & Retail, Food Products, Agricultural Industries, Governmen...
$ 3750
Cannabis Testing Services Comprehensive Study by Type (Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing/Residual Solvent Screening), Application (Labor...
$ 3750
Receptor Internalization Analysis Comprehensive Study by Type (Antibody Internalization, Ligand Internalization), Application (Diagnostics Centers, Hospitals & Clinics, Research Institutes, Others), ...
$ 3750
Fluorescence in situ hybridization probe Comprehensive Study by Type (RNA, DNA), Application (Cancer Diagnosis, Genetic Disorders, Others), End-User (Research Institutes, Diagnostic Centre, Biotechno...
$ 3450